TY - JOUR
T1 - A homozygous mutation in the tight-junction protein JAM3 causes hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts
AU - Mochida, Ganeshwaran H.
AU - Ganesh, Vijay S.
AU - Felie, Jillian M.
AU - Gleason, Danielle
AU - Hill, R. Sean
AU - Clapham, Katie Rose
AU - Rakiec, Daniel
AU - Tan, Wen Hann
AU - Akawi, Nadia
AU - Al-Saffar, Muna
AU - Partlow, Jennifer N.
AU - Tinschert, Sigrid
AU - Barkovich, A. James
AU - Ali, Bassam
AU - Al-Gazali, Lihadh
AU - Walsh, Christopher A.
N1 - Funding Information:
We would like to thank the family for their participation in this research. SNP genotyping was performed at The W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University through the National Institutes of Health Neuroscience Microarray Consortium. We thank the Partners HealthCare Center for Personalized Genetic Medicine for establishing the lymphoblast cell lines. We thank Brenda J. Barry for coordinating patient studies and Philippe Schröter and Juliane Artelt for help with cell culture. This research was supported by grants from the National Institute of Neurological Disorders and Stroke (5R01NS035129-13) and Fogarty International Center (5R21TW008223-02) to C.A.W. and by the Nancy Lurie Marks Family Foundation, the Dubai Harvard Foundation for Medical Research, the Simons Foundation, and the Manton Center for Orphan Disease Research. G.H.M. was supported by the Young Investigator Award of the National Alliance for Research on Schizophrenia and Depression (NARSAD) as a NARSAD Lieber Investigator. C.A.W. is an Investigator of the Howard Hughes Medical Institute.
PY - 2010/12/10
Y1 - 2010/12/10
N2 - The tight junction, or zonula occludens, is a specialized cell-cell junction that regulates epithelial and endothelial permeability, and it is an essential component of the blood-brain barrier in the cerebrovascular endothelium. In addition to functioning as a diffusion barrier, tight junctions are also involved in signal transduction. In this study, we identified a homozygous mutation in the tight-junction protein gene JAM3 in a large consanguineous family from the United Arab Emirates. Some members of this family had a rare autosomal-recessive syndrome characterized by severe hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Their clinical presentation overlaps with some reported cases of pseudo-TORCH syndrome as well as with cases involving mutations in occludin, another component of the tight-junction complex. However, massive intracranial hemorrhage distinguishes these patients from others. Homozygosity mapping identified the disease locus in this family on chromosome 11q25 with a maximum multipoint LOD score of 6.15. Sequence analysis of genes in the candidate interval uncovered a mutation in the canonical splice-donor site of intron 5 of JAM3. RT-PCR analysis of a patient lymphoblast cell line confirmed abnormal splicing, leading to a frameshift mutation with early termination. JAM3 is known to be present in vascular endothelium, although its roles in cerebral vasculature have not been implicated. Our results suggest that JAM3 is essential for maintaining the integrity of the cerebrovascular endothelium as well as for normal lens development in humans.
AB - The tight junction, or zonula occludens, is a specialized cell-cell junction that regulates epithelial and endothelial permeability, and it is an essential component of the blood-brain barrier in the cerebrovascular endothelium. In addition to functioning as a diffusion barrier, tight junctions are also involved in signal transduction. In this study, we identified a homozygous mutation in the tight-junction protein gene JAM3 in a large consanguineous family from the United Arab Emirates. Some members of this family had a rare autosomal-recessive syndrome characterized by severe hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Their clinical presentation overlaps with some reported cases of pseudo-TORCH syndrome as well as with cases involving mutations in occludin, another component of the tight-junction complex. However, massive intracranial hemorrhage distinguishes these patients from others. Homozygosity mapping identified the disease locus in this family on chromosome 11q25 with a maximum multipoint LOD score of 6.15. Sequence analysis of genes in the candidate interval uncovered a mutation in the canonical splice-donor site of intron 5 of JAM3. RT-PCR analysis of a patient lymphoblast cell line confirmed abnormal splicing, leading to a frameshift mutation with early termination. JAM3 is known to be present in vascular endothelium, although its roles in cerebral vasculature have not been implicated. Our results suggest that JAM3 is essential for maintaining the integrity of the cerebrovascular endothelium as well as for normal lens development in humans.
UR - http://www.scopus.com/inward/record.url?scp=78649789071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649789071&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2010.10.026
DO - 10.1016/j.ajhg.2010.10.026
M3 - Article
C2 - 21109224
AN - SCOPUS:78649789071
SN - 0002-9297
VL - 87
SP - 882
EP - 889
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 6
ER -